Zoloft craniosynostosis lawsuit filed in Pennsylvania

Another mother has filed a lawsuit against Pfizer, the maker of Zoloft, in the U.S. District Court for the Eastern District of Pennsylvania in Philadelphia ,PA. Her suit joins the Zoloft MDL, multidistrict litigation made up of currently pending lawsuits alleging Zoloft birth defects. She alleges that Pfizer’s selective serotonin reuptake Inhibiter (SSRI) antidepressant Zoloft caused her daughter’s birth defect.

Unaware of the risks, the woman began taking Zoloft in March 2010, before she became pregnant, and continued to take the antidepressant all through her her pregnancy. In August 2011, she gave birth to a baby girl and was told the child suffered from craniosynostosis. This cranial defect inhibits normal brain and skull growth due to the premature closing of the joints connecting the bony plates in the skull. In March 2012, the child had to undergo surgery called a craniotomy to correct the skull defects. The mother alleges that Pfizer should have known its product could affect unborn children.

The lawsuit alleges that as a result of her craniosynostosis, the child has been “deprived of having a normal childhood and life.” Sadly, the mother is aware that her child will continue have testing and appointments and continues to suffer physically and emotionally. She is seeking damages for medical costs and pain and suffering on behalf of her daughter. The lawsuit further indicates that Pfizer should have known of the potential for harm due to animal studies that have indicated a link between Zoloft and birth defects. According to the complaint, Pfizer knew of the link as early as 1996. Without regard for possible harm to pregnant women and their children, Pfizer actively encouraged doctors to prescribe the drug and to market the drug to pregnant women.

The first jury trial of the Zoloft MDL currently is scheduled to be in October 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *